Equity Profile

CTEV

Claritev Corporation

Health CareHealth Care Technology$508.7M

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Claritev Corporation (CTEV) operates in the health care technology sector, focusing on innovative solutions to improve patient care and streamline healthcare processes. With a market cap of $1 billion, the company is part of a growing industry that increasingly leverages technology to enhance health outcomes and operational efficiency.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and financial health.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing expectations by nearly 16%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, given the company's history of missing EPS estimates. The lack of guidance adds to uncertainty.

Bull Case

If Claritev can show signs of narrowing losses and potential revenue growth, it may restore investor confidence and lead to a positive stock reaction.

Bear Case

Continued losses and lack of revenue growth could lead to further declines in stock price, especially given the high implied volatility in the options market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current EPS and revenue forecast for Q2-2026?

Given the company's history of missing estimates, clarity on these figures will be crucial for investor sentiment.

What strategies is management implementing to improve financial performance?

Investors will be looking for actionable plans that could indicate a turnaround in the company's fortunes.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly pessimistic about Claritev's ability to improve its EPS, given recent technological advancements in its product offerings.

Supporting Evidence

The options market is pricing a 57.32% move, indicating expectations of volatility that may not materialize if results are stable.

Historical data shows that even with misses, the stock has often rebounded, suggesting potential for recovery.

Key Risk

If EPS comes in below -$4.50, it could reinforce negative sentiment and lead to further declines.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Claritev can turn around its financial performance after a series of disappointing earnings.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would indicate progress towards profitability.

Bear Confirmed If

If EPS remains above -$4.50, it could signal ongoing struggles and lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If the company beats expectations, history suggests a potential stock increase of around 6.82%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report could lead to muted reactions, as investors await more clarity on future guidance.

Miss

If the company misses again, the stock could drop, with historical patterns indicating an average decline of around 6.82%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technological advancements.
2Management's commentary on cost-cutting measures and their impact on EPS.
3Insights into customer acquisition and retention rates.
4Details on market expansion plans and revenue projections.
5Any discussion of partnerships or collaborations that could enhance growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and financial health.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing expectations by nearly 16%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautious ahead of the earnings report, given the company's history of missing EPS estimates. The lack of guidance adds to uncertainty.

Bull Case

If Claritev can show signs of narrowing losses and potential revenue growth, it may restore investor confidence and lead to a positive stock reaction.

Bear Case

Continued losses and lack of revenue growth could lead to further declines in stock price, especially given the high implied volatility in the options market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current EPS and revenue forecast for Q2-2026?

Given the company's history of missing estimates, clarity on these figures will be crucial for investor sentiment.

What strategies is management implementing to improve financial performance?

Investors will be looking for actionable plans that could indicate a turnaround in the company's fortunes.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be overly pessimistic about Claritev's ability to improve its EPS, given recent technological advancements in its product offerings.

Supporting Evidence

The options market is pricing a 57.32% move, indicating expectations of volatility that may not materialize if results are stable.

Historical data shows that even with misses, the stock has often rebounded, suggesting potential for recovery.

Key Risk

If EPS comes in below -$4.50, it could reinforce negative sentiment and lead to further declines.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Claritev can turn around its financial performance after a series of disappointing earnings.

Bull Confirmed If

A reduction in EPS losses to below -$3.50 would indicate progress towards profitability.

Bear Confirmed If

If EPS remains above -$4.50, it could signal ongoing struggles and lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If the company beats expectations, history suggests a potential stock increase of around 6.82%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report could lead to muted reactions, as investors await more clarity on future guidance.

Miss

If the company misses again, the stock could drop, with historical patterns indicating an average decline of around 6.82%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technological advancements.
2Management's commentary on cost-cutting measures and their impact on EPS.
3Insights into customer acquisition and retention rates.
4Details on market expansion plans and revenue projections.
5Any discussion of partnerships or collaborations that could enhance growth.